NCT03211091

Brief Summary

Patients with stroke were registered based on the WHO/ MONICA protocol and were followed-up for 28 days, starting in 2015 in PROVE Registry

Trial Health

35
At Risk

Trial Health Score

Automated assessment based on enrollment pace, timeline, and geographic reach

Trial has exceeded expected completion date
Enrollment
5,000

participants targeted

Target at P75+ for all trials

Timeline
Completed

Started Jan 2015

Longer than P75 for all trials

Status
unknown

Health score is calculated from publicly available data and should be used for screening purposes only.

Trial Relationships

Click on a node to explore related trials.

Study Timeline

Key milestones and dates

Study Start

First participant enrolled

January 1, 2015

Completed
2 years until next milestone

Primary Completion

Last participant's last visit for primary outcome

January 10, 2017

Completed
3 months until next milestone

First Submitted

Initial submission to the registry

April 24, 2017

Completed
2 months until next milestone

First Posted

Study publicly available on registry

July 7, 2017

Completed
2.5 years until next milestone

Study Completion

Last participant's last visit for all outcomes

January 1, 2020

Completed
Last Updated

July 7, 2017

Status Verified

July 1, 2017

Enrollment Period

2 years

First QC Date

April 24, 2017

Last Update Submit

July 5, 2017

Conditions

Outcome Measures

Primary Outcomes (1)

  • disability

    the Barthel Index

    3 months

Secondary Outcomes (2)

  • rehabilitation

    3 months

  • rehabilitation

    12 months

Eligibility Criteria

Age15 Years - 90 Years
Sexall
Healthy VolunteersNo
Age GroupsChild (0-17), Adult (18-64), Older Adult (65+)
Sampling MethodNon-Probability Sample
Study Population

patients with stroke or stroke history

You may qualify if:

  • \* patients with acute Stroke (Hemorrhagic and Non Hemorrhagic)

You may not qualify if:

  • patients who do not agree to continue cooperation
  • patients with incomplete documents

Contact the study team to confirm eligibility.

Sponsors & Collaborators

MeSH Terms

Conditions

Cerebrovascular Disorders

Condition Hierarchy (Ancestors)

Brain DiseasesCentral Nervous System DiseasesNervous System DiseasesVascular DiseasesCardiovascular Diseases

Study Design

Study Type
observational
Observational Model
COHORT
Time Perspective
PROSPECTIVE
Target Duration
2 Years
Sponsor Type
OTHER
Responsible Party
PRINCIPAL INVESTIGATOR
PI Title
Professor Mohammad Saadatnia

Study Record Dates

First Submitted

April 24, 2017

First Posted

July 7, 2017

Study Start

January 1, 2015

Primary Completion

January 10, 2017

Study Completion

January 1, 2020

Last Updated

July 7, 2017

Record last verified: 2017-07